113 related articles for article (PubMed ID: 30167909)
1. ASO Author Reflections: Hypoxia-Induced PLOD2 Is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
Okumura Y; Eguchi H
Ann Surg Oncol; 2018 Nov; 25(12):3738-3739. PubMed ID: 30167909
[No Abstract] [Full Text] [Related]
2. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
Okumura Y; Noda T; Eguchi H; Sakamoto T; Iwagami Y; Yamada D; Asaoka T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Ann Surg Oncol; 2018 Nov; 25(12):3728-3737. PubMed ID: 30105440
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.
Song Y; Zheng S; Wang J; Long H; Fang L; Wang G; Li Z; Que T; Liu Y; Li Y; Zhang X; Fang W; Qi S
Oncotarget; 2017 Jun; 8(26):41947-41962. PubMed ID: 28410212
[TBL] [Abstract][Full Text] [Related]
4. NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
Kiesslich T; Mayr C; Neureiter D
EBioMedicine; 2019 Nov; 49():9-10. PubMed ID: 31648982
[No Abstract] [Full Text] [Related]
5. [Invasion and metastasis of biliary tract cancer].
Hamada S; Masamune A; Shimosegawa T
Nihon Rinsho; 2015 Mar; 73 Suppl 3():461-5. PubMed ID: 25857068
[No Abstract] [Full Text] [Related]
6. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
7. The PLOD2/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness.
Tong Y; Qi Y; Xiong G; Li J; Scott TL; Chen J; He D; Li L; Wang C; Lane AN; Xu R
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2214942120. PubMed ID: 37155842
[TBL] [Abstract][Full Text] [Related]
8. PLOD2 in cancer research.
Du H; Pang M; Hou X; Yuan S; Sun L
Biomed Pharmacother; 2017 Jun; 90():670-676. PubMed ID: 28415047
[TBL] [Abstract][Full Text] [Related]
9. Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 Expression in Brain Arteriovenous Malformations and its Association with Brain Arteriovenous Malformation Size.
Neyazi B; Tanrikulu L; Wilkens L; Hartmann C; Stein KP; Dumitru CA; Sandalcioglu IE
World Neurosurg; 2017 Jun; 102():79-84. PubMed ID: 28279775
[TBL] [Abstract][Full Text] [Related]
10. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.
Noda T; Yamamoto H; Takemasa I; Yamada D; Uemura M; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Liver Int; 2012 Jan; 32(1):110-8. PubMed ID: 22098155
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary cancer: All efforts for one goal.
Su C
Cancer Lett; 2016 Sep; 379(2):164-5. PubMed ID: 27054486
[No Abstract] [Full Text] [Related]
12. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib.
Wiedmann M; Feisthammel J; Blüthner T; Tannapfel A; Kamenz T; Kluge A; Mössner J; Caca K
Anticancer Drugs; 2006 Aug; 17(7):783-95. PubMed ID: 16926628
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility.
Sada M; Ohuchida K; Horioka K; Okumura T; Moriyama T; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Nakamura M
Cancer Lett; 2016 Mar; 372(2):210-8. PubMed ID: 26805763
[TBL] [Abstract][Full Text] [Related]
14. PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.
Du H; Chen Y; Hou X; Huang Y; Wei X; Yu X; Feng S; Wu Y; Zhan M; Shi X; Lin S; Lu L; Yuan S; Sun L
Cell Death Dis; 2017 Oct; 8(10):e3143. PubMed ID: 29072684
[TBL] [Abstract][Full Text] [Related]
15. Biliary tract cancer stem cells - translational options and challenges.
Mayr C; Ocker M; Ritter M; Pichler M; Neureiter D; Kiesslich T
World J Gastroenterol; 2017 Apr; 23(14):2470-2482. PubMed ID: 28465631
[TBL] [Abstract][Full Text] [Related]
16. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches for the management of biliary tract cancer: today and tomorrow.
Rizzo A
Expert Opin Investig Drugs; 2021 Apr; 30(4):295-297. PubMed ID: 33626999
[No Abstract] [Full Text] [Related]
18. Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.
Limani P; Linecker M; Kron P; Samaras P; Pestalozzi B; Stupp R; Jetter A; Dutkowski P; Müllhaupt B; Schlegel A; Nicolau C; Lehn JM; Petrowsky H; Humar B; Graf R; Clavien PA
BMC Cancer; 2016 Oct; 16(1):812. PubMed ID: 27756258
[TBL] [Abstract][Full Text] [Related]
19. Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial-Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1
Qian J; Shen S; Chen W; Chen N
Biomed Res Int; 2018; 2018():4174232. PubMed ID: 29568752
[TBL] [Abstract][Full Text] [Related]
20. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma.
Jiao M; Nan KJ
Int J Oncol; 2012 Feb; 40(2):461-8. PubMed ID: 21922131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
